Mangoceuticals Inc. recently completed several share transactions. On June 2, 2025, Abri Advisors Ltd. exercised warrants to purchase 93,731 shares of common stock via a cashless exercise, valuing surrendered shares at $1.50 each. On the same day, Clover Crest Bahamas Ltd. exercised warrants to purchase 131,250 shares of common stock, also through a cashless exercise, at the same per-share value. Additionally, on June 5, 2025, Mangoceuticals sold 100,000 shares of common stock to Platinum Point Capital under an Equity Purchase Agreement for $1.9319 per share, totaling $193,190.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。